Meglipride MP 1mg/500mg/15mg Tablet
Marketer
LifeCare Formulation Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Meglipride MP 1mg/500mg/15mg Tablet
The combined medication Meglipride MP (1mg/500mg/15mg) assists in managing blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin effectiveness, thus reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Administering this tablet with food minimizes stomach irritation. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Excessive intake risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed before prescription. Limit alcohol consumption to reduce potential side effects.
Uses of Meglipride MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Meglipride MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Meglipride MP 1mg/500mg/15mg Tablet with food.
Common Side effects of Meglipride MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Meglipride MP 1mg/500mg/15mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Meglipride MP 1mg/500mg/15mg Tablets with food.
How Meglipride MP 1mg/500mg/15mg Tablet works:
Meglipride MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Meglipride MP 1mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Meglipride MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Meglipride MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Meglipride MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Meglipride MP 1mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. Meglipride MP 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Meglipride MP 1mg/500mg/15mg Tablet :
Should you forget to take your Meglipride MP 1mg/500mg/15mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Meglipride MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently